Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

A new at-home saliva test for prostate cancer could outperform current testing methods, a new study suggests. Researchers have developed a simple spit test, that can be performed at home and does not ...

A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...

Former President Joe Biden received his last known blood test to check for prostate cancer in 2014, a spokesperson said Tuesday — two days after Biden revealed he has an aggressive form of prostate ...

About one in every three men who have a positive blood test for prostate cancer are unlikely to develop the disease and may instead suffer problems from unnecessary surgeries or treatment, according ...

Rishi Sunak has urged men to be checked for prostate cancer as part of a new screening drive. The former prime minister has ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

WASHINGTON D.C. (WPVI) -- The Preventive Services Task Force is changing recommendations that can affect millions of middle-aged men. Five years ago, it opposed routine screening for prostate cancer, ...

A federal panel’s controversial recommendation that healthy men older than 50 avoid a PSA-based prostate screening test is drawing scorn from some doctors. The U.S. Preventive Services Task Force, an ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...